Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Adaptol

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
AIM To assess the efficacy and safety of adaptol in anxiety-asthenic disorders in patients with chronic cerebral ischemia (CCI… Expand
2016
2016
AIM To compare the effects of the daytime anxiolytic adaptol and the tranquilizer/nootropic drug noophen on target symptoms… Expand
2014
2014
OBJECTIVE To study clinical/psychological characteristics of neurasthenia and residual asthenia and to assess the efficacy of… Expand
2013
2013
AIM To evaluate the efficacy and safety of adaptol in a dose of 1500-2000 mg/day in combination therapy for anxiety disorders (AD… Expand
2013
2013
The efficacy of using Adaptol in the complex treatment of patients with autonomic-vascular dystonia following closed… Expand
  • table 1
  • figure 1
  • table 2
2013
2013
AIM: To evaluate the effect of the anxiolytic adaptol on blood pressure (BP) level in its concurrent use with a fixed dose… Expand
2013
2013
There is a presents a clinical case of idiopathic ventricular arrhythmia developing in a 27-year-old young woman with anxiety… Expand
2012
2012
We have studied the efficacy of adaptol in the treatment of 45 patients with somatoform dysfunction of the autonomic nervous… Expand
2011
2011
A total of 336 children aged 7–14 years with signs of school maladaptation (SMA) were studied. Anxiety disorders were detected in… Expand
  • table 1
  • table 2
2010
2010
acterized by weakness, increased fatigue, emotional lability, and sleep disturbances. Asthenia is one of the most common… Expand
  • table 1
  • table 2